SEC Form 4 · accession 0001209191-17-019588

Foundation Medicine, Inc. · FMI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Mar 7, 2017

Accepted (ET)

Mar 9, 2017 · 4:10 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001488613

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Mar 7, 2017	M	30,511	$7.12	A	353,144	D
Common Stock^F1	Mar 7, 2017	S	30,511	$34.31	D	322,633	D
Common Stock	Mar 8, 2017	M	9,489	$7.12	A	332,122	D
Common Stock^F2	Mar 8, 2017	S	9,489	$34.28	D	322,633	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
stock option (right to buy)^F3	$7.12	Mar 7, 2017	M	30,511	D	—	May 21, 2023	common stock	30,511	35,114	D
stock option (right to buy)^F3	$7.12	Mar 8, 2017	M	9,489	D	—	May 21, 2023	common stock	9,489	25,625	D

F1The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.30 to $34.35, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
F2The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.05 to $34.40, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
F3This stock option was granted on May 21, 2013 and vested in full on April 7, 2015.